We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.73B
AUM Growth
+$122M
Cap. Flow
-$305M
Cap. Flow %
-5.31%
Top 10 Hldgs %
36.62%
Holding
266
New
17
Increased
50
Reduced
179
Closed
19

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$54.5M
2
NVO
Novo Nordisk
NVO
+$53.8M
3
ABNB icon
Airbnb
ABNB
+$35.5M
4
BNTX icon
BioNTech
BNTX
+$22.3M
5
NVDA icon
NVIDIA
NVDA
+$16.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$45.6M
2
OKTA icon
Okta
OKTA
+$43.1M
3
ROKU icon
Roku
ROKU
+$38.5M
4
ENPH icon
Enphase Energy
ENPH
+$37.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$31.1M

Sector Composition

Rank Sector Weight
1 Technology 32.17%
2 Consumer Discretionary 24.08%
3 Healthcare 19.02%
4 Industrials 8.18%
5 Communication Services 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
176
Kymera Therapeutics
KYMR
$9.44B
$1.77M 0.03%
81,194
-13,879
-15% -$366K
KRTX
177
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.72M 0.03%
+7,629
New +$1.54M
WOLF icon
178
Wolfspeed
WOLF
$1.24B
$1.71M 0.03%
16,493
-12
-0.1% -$1.15K
GFS icon
179
GlobalFoundries
GFS
$24B
$1.7M 0.03%
35,132
-819
-2% -$44.1K
RENT
180
Rent the Runway
RENT
$63.8M
$1.67M 0.03%
37,938
-196,453
-84% -$16.1M
JPM icon
181
JPMorgan Chase
JPM
$928B
$1.66M 0.03%
15,856
+80
+0.5% +$9.18K
VZLA
182
Vizsla Silver
VZLA
$1.34B
$1.57M 0.03%
1,369,143
-13,222
-1% -$15.2K
BLZE icon
183
Backblaze
BLZE
$795M
$1.52M 0.03%
+305,933
New +$1.84M
RNLX
184
DELISTED
Renalytix plc American Depositary Shares
RNLX
$1.52M 0.03%
1,185,863
-372,421
-24% -$811K
ATVI
185
DELISTED
Activision Blizzard
ATVI
$1.5M 0.03%
20,139
-341
-2% -$26.7K
RVNC
186
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.43M 0.02%
+52,942
New +$1.07M
GTX icon
187
Garrett Motion
GTX
$4.9B
$1.35M 0.02%
238,695
+526
+0.2% +$3.61K
AUPH icon
188
Aurinia Pharmaceuticals
AUPH
$2.15B
$1.35M 0.02%
179,090
-876
-0.5% -$7.58K
ISEE
189
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$1.3M 0.02%
72,325
-24,843
-26% -$326K
CYTK icon
190
Cytokinetics
CYTK
$9.91B
$1.25M 0.02%
+25,835
New +$1.24M
PODD icon
191
Insulet
PODD
$9.52B
$1.21M 0.02%
+5,269
New +$1.32M
BRK.B icon
192
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.16M 0.02%
4,335
-13
-0.3% -$3.7K
CP icon
193
Canadian Pacific Kansas City
CP
$78.6B
$1.14M 0.02%
17,140
-241
-1% -$18.2K
VEEV icon
194
Veeva Systems
VEEV
$42.6B
$1.1M 0.02%
6,655
-116
-2% -$23.2K
SG icon
195
Sweetgreen
SG
$852M
$1.06M 0.02%
57,133
+2,939
+5% +$50.1K
SHW icon
196
Sherwin-Williams
SHW
$77.6B
$1.04M 0.02%
5,075
+100
+2% +$23.7K
SBUX icon
197
Starbucks
SBUX
$112B
$1.04M 0.02%
12,290
-33
-0.3% -$2.8K
DNTH icon
198
Dianthus Therapeutics
DNTH
$5.98B
$994K 0.02%
44,076
-2,548
-5% -$69.8K
ASPN icon
199
Aspen Aerogels
ASPN
$405M
$932K 0.02%
101,042
-100
-0.1% -$1.21K
ARLO icon
200
Arlo Technologies
ARLO
$1.48B
$901K 0.02%
194,202
+6,724
+4% +$42.1K
6 7
8
9 10

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Gilder Gagnon Howe & Co held 266 positions worth $5.73B, up 2.2% from $5.61B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $305M in Q3 2022, closing 19 positions and reducing 179 holdings. Its most notable exit was 1Life Healthcare, an estimated $23.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Novo Nordisk worth $50M.

  • Gilder Gagnon Howe & Co's largest Q3 2022 buy was Novo Nordisk: 1,004,430 shares worth $50M.
  • Gilder Gagnon Howe & Co added most to Eli Lilly in Q3 2022, an estimated $54.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $45.6M.
  • Gilder Gagnon Howe & Co fully exited 1Life Healthcare in Q3 2022, selling an estimated $23.4M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 37% of its $5.73B portfolio in Q3 2022.
  • Gilder Gagnon Howe & Co opened 17 new positions and closed 19 in Q3 2022.
  • Gilder Gagnon Howe & Co's portfolio value rose 2.2% quarter-over-quarter to $5.73B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.